$NVAX News

Last published 1d ago

1d agoNVAXNovavax to Participate in Jefferies London Healthcare ConferencePR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conference: Jefferies...
1w agoNVAXNOVAVAX INC - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
2w agoNVAXNovavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in EuropePR NewswireThe global flu and COVID-19 markets have a current combined value that exceeds $10 billion, with significant burden of disease1The combination vaccine candidate evaluated in this trial pairs Sanofi's leading
2w agoNVAXNovavax to Report Third Quarter 2026 Financial Results on November 5, 2026PR NewswireGAITHERSBURG, Md., Oct. 29, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced that the Company plans to release its third quarter 2026 financial results before the open of the U.S. financial markets on
2mo agoNVAXNovavax to Participate in September Investor ConferencesPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conferences: 2026 Cantor...
2mo agoNVAXNovavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination SeasonPR NewswireNovavax, Inc.'s (Nasdaq: NVAX) partners have received approvals for the Nuvaxovid™ formulation to target the SARS-CoV-2 XFG variant for the 2026-2027 ...
3mo agoNVAXNovavax Reports Second Quarter 2026 Financial Results and Operational HighlightsPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the second quarter ended June 30, 2026. "We're...
3mo agoNVAXNovavax to Report Second Quarter 2026 Financial Results on August 6, 2026PR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that the Company plans to release its second quarter 2026 financial results before the open of the U.S....
5mo agoNVAXNovavax to Participate in 2026 Jefferies Global Healthcare ConferencePR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference. Conference Details: Fireside...
6mo agoMRNA INO NVAX EBSHantavirus cases spark surge in pharma and biotech stocks — here’s whyCNBCThe outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
6mo agoNVAXNovavax to Participate in BofA Securities 2026 Health Care ConferencePR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference. Conference Details:...
6mo agoNVAXNovavax Reports First Quarter 2026 Financial Results and Operational HighlightsPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the first quarter ended March 31, 2026. "Novavax...
6mo agoNVAXNovavax to Report First Quarter 2026 Financial Results on May 6, 2026PR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2026 financial results and operational highlights at 8:30 a.m. Eastern...
7mo agoNVAXNovavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & DevelopmentPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development ...
8mo agoNVAXNovavax to Participate in Upcoming Investor ConferencesPR NewswireNovavax, Inc. (Nasdaq: NVAX), today announced that it will participate in the following upcoming investor conferences: TD Cowen 46th Annual Health...
8mo agoNVAXNovavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational HighlightsPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025....
8mo agoNVAXNovavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026PR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced it will report its fourth quarter and full year 2025 financial results and operational highlights at...
9mo agoNVAXNovavax Announces Entering into a License Agreement with PfizerPR NewswireNovavax, Inc. (Nasdaq: NVAX) has entered into a license agreement with Pfizer for use of Novavax's Matrix-M® adjuvant. Under the terms of the...
10mo agoNVAXNovavax to Participate in the 44th Annual J.P. Morgan Healthcare ConferencePR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference. Conference Details:...
1y agoNVAXNovavax to Participate in Jefferies London Healthcare ConferencePR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference: Jefferies London Healthcare...
1y agoNVAXNovavax Reports Third Quarter 2025 Financial Results and Operational HighlightsPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended September 30, 2025. "We...
1y agoNVAXNovavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone PaymentPR NewswireNovavax, Inc. (Nasdaq: NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovid™ to Sanofi, enabling...
1y agoNVAXNovavax to Report Third Quarter 2025 Financial Results on November 6, 2025PR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern...
1y agoNVAXNovavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate StrategyPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that it has further executed against its planned transformation into a lean, agile operating model by...
1y agoNVAXNovavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone PaymentPR NewswireNovavax, Inc. (Nasdaq: NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® to Sanofi, in the...
1y agoNVAXNovavax Announces Progress on Sanofi AgreementPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced progress on its collaboration and license agreement (CLA) with Sanofi regarding Novavax's Matrix-M®...
1y agoPFE MRNA NVAXPfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shotsCNBCThe report says officials plan to include the claim in a presentation next week to a key vaccine panel that advises the CDC on shot access and coverage.
1y agoNVAXNovavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 TranscriptEarnings Call Transcripts
1y agoNVAXNuvaxovid® Now Approved in Japan Triggering Takeda Milestone PaymentPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced a milestone payment* from Takeda has been triggered by regulatory approval for Novavax's COVID-19...
1y agoNVAXNovavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.PR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration has approved the Nuvaxovid™ 2025-2026 Formula for the...
1y agoMRNA PFE NVAXFDA approves new Covid shots with limits on who can get them under RFK Jr.CNBCIt's unclear how easily patients without high risk factors will be able to get a Covid shot, and whether insurance plans will still cover them.
1y agoNVAXNovavax Announces Convertible Debt RefinancingPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that it has entered into privately negotiated agreements with certain of the holders of its existing...
1y agoPFE MRNA NVAXFDA may pull authorization of Pfizer's Covid vaccine for children under 5, company saysCNBCThe potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots against Covid.
1y agoNVAXNovavax, Inc. (NVAX) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoNVAXNovavax Reports Second Quarter 2025 Financial Results and Operational HighlightsPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the second quarter ended June 30, 2025. "This...
1y agoNVAXNovavax to Report Second Quarter 2025 Financial Results on August 6, 2025PR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced it will report its second quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern ...
1y agoNVAXNovavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical StudyPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced preclinical data demonstrating that Novavax's H5N1 avian pandemic influenza vaccine candidate,...
1y agoMRNA PFE NVAXModerna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shotCNBCThe phase three study data clears the path forward for Moderna's combination jab targeting Covid-19 and influenza.
1y agoNVAXNovavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 TrialPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent...
1y agoNVAXNovavax to Participate in Upcoming Investor ConferencesPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conferences: Jefferies Global Healthcare...
1y agoNVAX PFE MRNAHealthy Returns: Novavax scores narrower Covid vaccine approval after delayCNBCThe FDA approved Novavax's Covid-19 vaccine but with unusual restrictions.
1y agoNVAXU.S. FDA Approves BLA for Novavax's COVID-19 VaccinePR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA)...
1y agoNVAXNovavax Reports First Quarter 2025 Financial Results and Operational HighlightsPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the first quarter ended March 31, 2025. "I am...
1y agoNVAXNovavax to Participate in BofA Securities 2025 Health Care ConferencePR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2025 Health Care Conference. Conference Details:...
1y agoNVAXNovavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in JapanPR NewswireNovavax, Inc. (Nasdaq: NVAX) has updated the terms of the previously announced collaboration and licensing agreement (CLA) with Takeda. The improved...
1y agoNVAXNovavax to Report First Quarter 2025 Financial Results on May 8, 2025PR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern...
1y agoNVAXNovavax Appoints Charles Newton to Board of DirectorsPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced the appointment of Charles Newton to its board as an independent director. Mr. Newton brings extensive...
1y agoNVAXSHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNAPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced preliminary results from the SHIELD-Utah study (Study of Healthcare Workers and First Responders...
1y agoMRNA NVAX XBIVaccine stocks fall after key FDA official resigns in protest of RFK Jr.CNBCShares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks's resignation in protest of Robert F. Kennedy Jr.
1y agoNVAXNovavax Announces Changes to Board of DirectorsPR NewswireNovavax, Inc. (Nasdaq: NVAX) today announced that James Young, PhD, is retiring as Chair of the Board and Margaret McGlynn, RPh, has been appointed...